Largely overshadowed by the opioid epidemic, deaths from psychostimulants increased more than 250% between 2008 and 2015 after a period of declining amphetamine use.
1,2 Use of amphetamines, primarily illicit methamphetamine hydrochloride, surged in the early 2000s and then began to decline in the mid-2000s as precursors to methamphetamine production were restricted.
3 Coinciding with an uptrend in psychostimulant deaths are increases in the demand and supply of high-purity, low-cost methamphetamine, as the US Drug Enforcement Administration recently reported.
1 In some US states, deaths from methamphetamine have surpassed deaths from heroin.
4 Preliminary evidence shows that amphetamine-related use of treatment facilities and emergency departments (EDs) has increased in the past several years.
5-7 Amphetamine use is now the fourth most common reason to seek drug treatment in the United States, after alcohol, opioid, and marijuana use.
5